These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes. Coughlan MT; Nguyen TV; Penfold SA; Higgins GC; Thallas-Bonke V; Tan SM; Van Bergen NJ; Sourris KC; Harcourt BE; Thorburn DR; Trounce IA; Cooper ME; Forbes JM Clin Sci (Lond); 2016 May; 130(9):711-20. PubMed ID: 26831938 [TBL] [Abstract][Full Text] [Related]
9. Mitochondrial dynamics: regulatory mechanisms and emerging role in renal pathophysiology. Zhan M; Brooks C; Liu F; Sun L; Dong Z Kidney Int; 2013 Apr; 83(4):568-81. PubMed ID: 23325082 [TBL] [Abstract][Full Text] [Related]
10. Challenging the dogma of mitochondrial reactive oxygen species overproduction in diabetic kidney disease. Coughlan MT; Sharma K Kidney Int; 2016 Aug; 90(2):272-279. PubMed ID: 27217197 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNAs in the pathogenesis of diabetic kidney disease: implications for novel therapeutic strategies. Leti F; Morrison E; DiStefano JK Per Med; 2017 May; 14(3):271-278. PubMed ID: 29767584 [TBL] [Abstract][Full Text] [Related]
12. Emerging role of lncRNAs in renal fibrosis. Chen H; Fan Y; Jing H; Tang S; Zhou J Arch Biochem Biophys; 2020 Oct; 692():108530. PubMed ID: 32768395 [TBL] [Abstract][Full Text] [Related]
13. Mitochondrial dysfunction and oxidative stress: Role in chronic kidney disease. Srivastava A; Tomar B; Sharma D; Rath SK Life Sci; 2023 Apr; 319():121432. PubMed ID: 36706833 [TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNAs and Their Therapeutic Promise in Diabetic Nephropathy. Coellar JD; Long J; Danesh FR Nephron; 2021; 145(4):404-414. PubMed ID: 33853077 [TBL] [Abstract][Full Text] [Related]
15. Diabetes and Kidney Disease: Role of Oxidative Stress. Jha JC; Banal C; Chow BS; Cooper ME; Jandeleit-Dahm K Antioxid Redox Signal; 2016 Oct; 25(12):657-684. PubMed ID: 26906673 [TBL] [Abstract][Full Text] [Related]
16. The Mitochondria-Targeted Metabolic Tubular Injury in Diabetic Kidney Disease. Jiang H; Shao X; Jia S; Qu L; Weng C; Shen X; Wang Y; Huang H; Wang Y; Wang C; Feng S; Wang M; Feng H; Geekiyanage S; Davidson AJ; Chen J Cell Physiol Biochem; 2019; 52(2):156-171. PubMed ID: 30816665 [TBL] [Abstract][Full Text] [Related]
17. Antioxidative Effects of Tempol on Mitochondrial Dysfunction in Diabetic Nephropathy. Ranjbar A; Kheiripour N; Ghasemi H; Seif Rabiei MA; Dadras F; Khoshjou F Iran J Kidney Dis; 2018 Mar; 12(2):84-90. PubMed ID: 29507270 [TBL] [Abstract][Full Text] [Related]
18. [Regulatory mechanisms of mitochondrial dynamics and its emerging role in renal pathophysiology]. Tan ZX; Zhu WZ Sheng Li Xue Bao; 2024 Feb; 76(1):148-160. PubMed ID: 38444140 [TBL] [Abstract][Full Text] [Related]
19. New Pathogenic Concepts and Therapeutic Approaches to Oxidative Stress in Chronic Kidney Disease. Pedraza-Chaverri J; Sánchez-Lozada LG; Osorio-Alonso H; Tapia E; Scholze A Oxid Med Cell Longev; 2016; 2016():6043601. PubMed ID: 27429711 [TBL] [Abstract][Full Text] [Related]
20. [Mitochondria and oxidative stress participation in renal inflammatory process]. Manucha W Medicina (B Aires); 2014; 74(3):254-8. PubMed ID: 24918679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]